Santhera Pharmaceuticals
SANN.SW
#8533
Rank
โ‚น12.05 B
Marketcap
โ‚น996.02
Share price
4.81%
Change (1 day)
2.14%
Change (1 year)

Revenue for Santhera Pharmaceuticals (SANN.SW)

Revenue in 2018 (TTM): โ‚น1.93 Billion

According to Santhera Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น2.40 Billion. In 2023 the company made a revenue of โ‚น10.44 Billion an increase over the revenue in the year 2022 that were of โ‚น0.68 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Santhera Pharmaceuticals from 2006 to 2018

Annual revenue

Year Revenue Change
2023โ‚น10.44 B1420.52%
2022โ‚น0.68 B-563.4%
2021-โ‚น0.15 Billion-110.25%
2020โ‚น1.44 B-78.12%
2019โ‚น6.60 B141.78%
2018 โ‚น2.73 B36.6%
2017 โ‚น2.00 B26.11%
2016โ‚น1.58 B327.21%
2015โ‚น0.37 B66.86%
2014โ‚น0.22 B76.3%
2013โ‚น0.12 B-61.65%
2012โ‚น0.32 B11.39%
2011โ‚น0.29 B-84.22%
2010โ‚น1.87 B2.1%
2009โ‚น1.83 B46831.09%
2008โ‚น3.9 M
2007N/A-100%
2006โ‚น54.51 M